@FierceMedDev: Do you know which med tech CEOs made the most money in 2013? Check out our report by @EmilyWFierce and @EmilyMFierce. Feature | Follow @FierceMedDev
@StacyALawrence: 2013's 10 highest-paid Med Tech CEOs - FierceMedicalDevices. Report | Follow @StacyALawrence
@VarunSaxena2: ICYMI: Patent office nomination for J&J top IP lawyer would send anti-reform message. Article | Follow @VarunSaxena2
@MichaelGFierce: A tiny, "walking" robot powered by a muscle cell? It could help deliver drugs one day. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: Effects of childhood trauma and adversity could be mistaken for ADHD, according to experts. More from The Atlantic | Follow @EmilyWFierce
> CareDx, a molecular diagnostic company for heart transplant patients, announced Monday its offering of 3.1 million shares at a price range of $15 to $17 in hopes of raising $50 million. The IPO is expected to launch next week. Story
> Another IPO is expected to price this week for oncology company Microlin Bio, a diagnostic and therapeutics biotech, with plans to raise $28 million by offering 5.5 million shares at $4.50 to $5.5. It should be noted that the IPO was expected during the previous two weeks as well, only to be delayed due to an ongoing slump in investor demand for biotech IPOs. Story
> San Diego-based NuVasive ($NUVA) is opening an international operations center in Ireland this week. The company plans to create up to 30 highly skilled roles over the next few years. Story
> The FDA announced that because the devices demonstrate reasonable assurance of safety and effectiveness, nonpowered lower extremity pressure wraps have been reclassified into Class I (general controls). Announcement
Biotech News
@FierceBiotech: $ENDP, $BDSI buoyed as PhIII pain drug success clears path to FDA. News | Follow @FierceBiotech
@JohnCFierce: FDA gives an early OK to lymphoma drug Beleodaq. Story | Follow @JohnCFierce
@DamianFierce: I have no idea what the next move for the Aragon/Seragon team is, but do note that Paragon Pharma is already taken. More | Follow @DamianFierce
@EmilyMFierce: Not to mention other zoonotic diseases. RT @MotherJones: We Are Making Ebola Outbreaks Worse By Cutting Down Forests. Article | Follow @EmilyMFierce
> Where's the U.K. outrage over AbbVie's pursuit of Shire? More
> Anti-PD-1 cancer star nivolumab wins world's first regulatory approval. News
> Essex Woodlands strides to a new $750M venture fund for biotech, healthcare. Article
Pharma News
@FiercePharma: Our newest site, FierceAnimalHealth, is up and running! Go look --> FierceAnimalHealth.com | Follow @FiercePharma
@EricPFierce: India generic makers, tired of being criticized will see if a PR campaign in the US can turn things around. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: RT @FiercePharma: Top-read in FierceVaccines: Agenus' genital herpes vax cuts viral load 75% in PhII. More | Follow @CarlyHFierce
> U.S. voices concern over closed trial of American linked to GSK scandal. Story
> U.K. fund manager Neil Woodford bets big on AstraZeneca. More
> EU approves GSK's Mekinist and Novartis will reap the rewards. Report
CRO News
> AMRI eyes a big year after completing another buyout. Article
> Quintiles extends its commercial capabilities with Encore buyout. News
> Catalent eyes a Japanese expansion after 40 years in the country. More
> BioOutsource plots a U.S. expansion with eyes on biosimilars. Story
> Parexel eyes the Middle East with its latest CRO buyout. Article
Biotech IT News
> The Silicon Valley startups aiming to build Amazon for biotech R&D. Story
> FDA wants an EMR database to boost oversight of drug safety. More
> FDA IT modernization push set to continue under 2014-2018 strategic plan. Article
> 'Painful' regulations keeping Google on the periphery of life sciences. Story
> Faculty leaders call for Scripps chief to leave over USC merger plan. Report
Animal Health News
> Animal health test company Idexx Laboratories opens $35M addition. News
> Injectable brace for horses could speed up healing time. Item
> Advaxis pushes into animal care with cancer immunotherapy. Article
> FDA begins to guide nanotechnology in animal feed. More
> Merck's Bravecto, Bayer's Quellin chewables approved for dogs. Story